{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-25-000089","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.168347+00:00","generated_at":"2026-05-17T00:02:53.904228+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Solventum Q3 organic sales +2.7%; raises FY adj. EPS guidance to $5.98-$6.08","bullets":["Q3 reported sales $2.1B (+0.7% YoY); organic sales +2.7% driven by Dental Solutions and HIS.","GAAP diluted EPS $7.22 (includes large non-recurring gains); adjusted diluted EPS $1.50, down 8.5% YoY.","Adjusted operating margin 20.6% down 220bps due to tariffs, public-company costs, growth investments.","Full-year adj. EPS guidance raised to $5.98-$6.08; organic sales growth at high end of +2-3%.","Announces 4-year 'Transform for the Future' initiative; operating cash flow $75M, FCF -$22M."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-25-000089","json":"https://secwatch.observer/filing/0001964738-25-000089.json","markdown":"https://secwatch.observer/filing/0001964738-25-000089.md","text":"https://secwatch.observer/filing/0001964738-25-000089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000089/0001964738-25-000089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000089/solv-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:02:53.904228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}